Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Forward in reverse: how reverse genetics complements chemical genetics.

Petra Ross-Macdonald1

  • 1Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 5400, Princeton, NJ 08543, USA. rossmacp@bms.com

Pharmacogenomics
|July 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy.

Science advances·2022
Same author

Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma.

Journal for immunotherapy of cancer·2022
Same author

Soluble PD-L1 as an early marker of progressive disease on nivolumab.

Journal for immunotherapy of cancer·2022
Same author

Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.

Journal for immunotherapy of cancer·2021
Same author

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.

Nature communications·2021

Connecting active compounds to their targets is crucial for drug discovery. This study proposes a systematic method to match chemical and genetic phenotypes, aiding in identifying compound targets and advancing therapeutic use.

Area of Science:

  • Drug discovery and chemical genomics
  • Pharmacology and molecular biology

Background:

  • Pharmaceutical research is increasingly focused on physiological screening.
  • Chemical genomics projects are generating vast amounts of cellular assay data.
  • Current methods for linking active compounds to their specific targets are limited.

Purpose of the Study:

  • To address the lack of robust approaches for connecting active compounds with their biological targets.
  • To establish a systematic method for identifying compound-target interactions.
  • To facilitate the experimental and therapeutic application of identified compounds.

Main Methods:

  • Systematic matching of chemical genetic phenotypes.
  • Integration with reverse genetic phenotypes.

Related Experiment Videos

  • Comparative analysis of phenotypic data.

    • Main Results:

    • A framework for connecting chemical compounds to their molecular targets was developed.
    • The proposed method enables the identification of potential drug targets from phenotypic data.
    • This approach provides a valuable starting point for numerous research investigations.

    Conclusions:

    • A systematic phenotype-matching approach is essential for advancing pharmaceutical discovery.
    • Connecting chemical genetic and reverse genetic phenotypes offers a powerful strategy for target identification.
    • This methodology will accelerate the development and application of novel therapeutics.